Cancer prevention videos and webinars related to DCP programs.
-
Speaker Xiaoshuang Feng, Ph.D. Scientist Cancer Epidemiology Branch International Agency for Research on Cancer (IARC) World Health Organization (WHO) Biography I am an early-career scientist working in…
-
Discover the Breast Cancer Symptom Explorer, a powerful research-facing tool for visualizing adverse events (AEs) and quality-of-life (QOL) data in breast cancer clinical trials. This video introduces the tool, explains its purpose, and demonstrates its four key applications.
-
Speaker Atieh Hajirahimkhan, Ph.D. NCI NRSA Postdoctoral Fellow Department of Surgery Lurie Cancer Center Translational Bridge Fellow Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine…
-
Age is the number one risk factor for cancer, yet older adults are often underrepresented in clinical trials. This video highlights groundbreaking research showing how geriatric assessments can improve cancer treatment tolerability for patients over 70.
-
This video explains the toxicity index—a powerful tool for analyzing and comparing the severity of side effects in patients undergoing treatment. First introduced by André Rogatko in 2004, the toxicity index has become a superior method for summarizing adverse events in clinical trials.
-
Discover the ProAE R Package: A powerful collection of statistical tools designed for the standardized analysis and visualization of patient-reported adverse event (AE) data in cancer clinical trials. This free and publicly available tool on the CRAN network is tailored to handle PRO-CTCAE and GP5
-
This webinar is rescheduled from January 28, 2025. Join us to kick off the 2025 season of Building Bridges in Cancer Symptom Science, where we will focus on the complex issue of cancer cachexia. Drs. Erin Talbert and Eric…
-
This webinar will focus on the role of cancer caregivers in promoting symptom management and optimal cancer outcomes. The speakers will discuss the importance of addressing caregivers’ wellbeing during cancer and interventions designed for the patient-caregiver dyad to optimize health and quality
-
In this installment of the Building Bridges in Cancer Symptom Science Webinar Series, the speakers focused on interventions for cancer-related cognitive impairment. Dr. Agnès Lacreuse discussed pharmacological interventions for cognitive decline induced by aromatase-inhibitor therapy in a...
-
Bladder cancer (BC) is one of the most frequently diagnosed neoplasms, with an estimated half a million new cases and 200,000 deaths per year worldwide. Men have a 3-4 times higher risk of developing bladder cancer than women.